SIMULECT
20MG INJ/INF PSO LQF 1+1X5ML AMP
| SÚKL code | 0027627 |
|---|---|
| Name of the product | SIMULECT |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | SIMULECT |
| Supplement | 20MG INJ/INF PSO LQF 1+1X5ML AMP |
| Strenght | 20MG |
| Pharmaceutical form | Powder and solvent for solution for injection/infusion |
| Package | 1+1X5ML AMP |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | BASILIXIMAB (BASILIXIMABUM) |
| ATC group | L04AC02 |
| ATC group name | BASILIXIMAB |
| Doping | Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/98/084/001 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Novartis Europharm Limited, Dublin |
| MA Holder country | IRSKO |
cz